<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03615612</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00157754</org_study_id>
    <nct_id>NCT03615612</nct_id>
  </id_info>
  <brief_title>Investigation of the Accuracy of a Low-cost, Portable, Autorefractor to Provide Well-tolerated Eyeglass Prescriptions</brief_title>
  <official_title>Investigation of the Accuracy of a Low-cost, Portable, Autorefractor to Provide Well-tolerated Eyeglass Prescriptions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PlenOptika</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aravind Eye Care System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      At the Aravind Eye Hospital (AEH) in Madurai, India, patients ages 18-40 receiving treatment
      for refractive error who choose to enroll in the study will be evaluated using subjective
      refraction and objective refraction, by way of the QuickSee autorefractor. Patients will then
      be randomized into one of two treatment plans: receive glasses from objective measure first
      then subjective measure second, and vice versa. After one week of wearing the first pair of
      glasses, patient preferences are assessed, and glasses are switched. After a week of wearing
      the second pair of glasses from the alternate measurement method, patient preferences are
      again assessed. Patients may then decide which pair patient like best. This is a double
      blind, case-crossover clinical trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 15, 2017</start_date>
  <completion_date type="Actual">August 30, 2019</completion_date>
  <primary_completion_date type="Actual">August 2, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Preference</measure>
    <time_frame>2 years</time_frame>
    <description>Patients are asked the question &quot;Which eyeglasses did you prefer?&quot;. Patient response is then recorded.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>OR Eyeglasses, then SR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Objective Refraction (OR) Eyeglasses, then Subjective Refraction (SR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SR Eyeglasses, then OR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjective Refraction (SR) Eyeglasses, then Objective Refraction (OR)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>QuickSee refractive error assessment + glasses</intervention_name>
    <description>QuickSee refractive error assessment + glasses</description>
    <arm_group_label>OR Eyeglasses, then SR</arm_group_label>
    <arm_group_label>SR Eyeglasses, then OR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Participants-

          1. who visit a Vision Center for their eye check-up

          2. who are aged between 18 years and 40 years

        Exclusion Criteria: Participants-

          1. whose refractive error is not within the detection range of the QuickSee device: -10
             to +10 D

          2. who have a cylindrical power greater than 3 D

          3. who have to travel long distances (beyond 10kms) to the hospital

          4. who choose to buy spectacles that are priced more than Rs. 2000/- per pair

          5. who have speech or hearing impairment

          6. who do not speak the local language, Tamil

          7. who do not want to purchase spectacles from AEH
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Friedman, MD, MPH, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aravind Eye Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 31, 2018</study_first_submitted>
  <study_first_submitted_qc>July 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>6 months</ipd_time_frame>
    <ipd_access_criteria>PlenOptika, Aravind Eye Hospital, Johns Hopkins</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

